Anna Steenpaß

400 total citations
8 papers, 326 citations indexed

About

Anna Steenpaß is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Anna Steenpaß has authored 8 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Molecular Biology. Recurrent topics in Anna Steenpaß's work include Hormonal and reproductive studies (2 papers), Receptor Mechanisms and Signaling (2 papers) and Sexual function and dysfunction studies (2 papers). Anna Steenpaß is often cited by papers focused on Hormonal and reproductive studies (2 papers), Receptor Mechanisms and Signaling (2 papers) and Sexual function and dysfunction studies (2 papers). Anna Steenpaß collaborates with scholars based in Germany, United States and Switzerland. Anna Steenpaß's co-authors include Rainer H. Böger, Ralf A. Benndorf, Süleyman Ergün, Thomas Wieland, Edzard Schwedhelm, Michael Didié, Renke Maas, Sönke Behrends, Hartmut Porst and Hasso Scholz and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Circulation Research.

In The Last Decade

Anna Steenpaß

8 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Steenpaß Germany 8 142 102 79 57 31 8 326
Sono Toi Japan 14 126 0.9× 121 1.2× 51 0.6× 29 0.5× 16 0.5× 55 505
Pilar J. Oviedo Spain 11 69 0.5× 101 1.0× 71 0.9× 149 2.6× 46 1.5× 15 431
Shin-ichiro Mita Japan 8 135 1.0× 130 1.3× 108 1.4× 115 2.0× 39 1.3× 11 369
Sara Bonomo Italy 13 79 0.6× 116 1.1× 126 1.6× 66 1.2× 27 0.9× 24 375
Yejun Zhao United States 9 80 0.6× 122 1.2× 71 0.9× 50 0.9× 55 1.8× 13 371
Jennifer A. Florian United States 7 89 0.6× 275 2.7× 118 1.5× 69 1.2× 26 0.8× 9 425
Tobias A. Marsen Germany 11 116 0.8× 99 1.0× 183 2.3× 32 0.6× 11 0.4× 20 410
Liliana Ercole Spain 11 127 0.9× 97 1.0× 85 1.1× 58 1.0× 18 0.6× 14 433
D KASS United States 6 256 1.8× 136 1.3× 83 1.1× 53 0.9× 8 0.3× 9 501
Arnar Rafnsson Sweden 9 122 0.9× 104 1.0× 169 2.1× 52 0.9× 14 0.5× 13 372

Countries citing papers authored by Anna Steenpaß

Since Specialization
Citations

This map shows the geographic impact of Anna Steenpaß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Steenpaß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Steenpaß more than expected).

Fields of papers citing papers by Anna Steenpaß

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Steenpaß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Steenpaß. The network helps show where Anna Steenpaß may publish in the future.

Co-authorship network of co-authors of Anna Steenpaß

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Steenpaß. A scholar is included among the top collaborators of Anna Steenpaß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Steenpaß. Anna Steenpaß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Flenner, Frederik, Christiane Jungen, Martin Kruse, et al.. (2021). Translational investigation of electrophysiology in hypertrophic cardiomyopathy. Journal of Molecular and Cellular Cardiology. 157. 77–89. 20 indexed citations
2.
Heilmann, Andreas, Michael Didié, Saskia Schlossarek, et al.. (2012). Impact of AT2 Receptor Deficiency on Postnatal Cardiovascular Development. PLoS ONE. 7(10). e47916–e47916. 10 indexed citations
4.
Maas, Renke, Kurt Quitzau, Edzard Schwedhelm, et al.. (2006). Asymmetrical dimethylarginine (ADMA) and coronary endothelial function in patients with coronary artery disease and mild hypercholesterolemia. Atherosclerosis. 191(1). 211–219. 37 indexed citations
5.
Maas, Renke, Sven Wenske, Rodolfo Ventura, et al.. (2005). Elevation of Asymmetrical Dimethylarginine (ADMA) and Coronary Artery Disease in Men with Erectile Dysfunction. European Urology. 48(6). 1004–1012. 23 indexed citations
6.
Maas, Renke, et al.. (2004). 865-3 Improvement of endothelium-dependent vasodilation by simvastatin is potentiated by combination with L-arginine in patients with elevated asymmetric dimethylarginine levels. Journal of the American College of Cardiology. 43(5). A525–A525. 15 indexed citations
7.
Benndorf, Ralf A., Rainer H. Böger, Süleyman Ergün, Anna Steenpaß, & Thomas Wieland. (2003). Angiotensin II Type 2 Receptor Inhibits Vascular Endothelial Growth Factor–Induced Migration and In Vitro Tube Formation of Human Endothelial Cells. Circulation Research. 93(5). 438–447. 104 indexed citations
8.
Behrends, Sönke, Anna Steenpaß, Hartmut Porst, & Hasso Scholz. (2000). Expression of nitric oxide-sensitive guanylyl cyclase subunits in human corpus cavernosum. Biochemical Pharmacology. 59(6). 713–717. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026